Dr. Hurria on Treatment Options for the Geriatric Population with Breast Cancer

Arti Hurria, MD
Published: Monday, Jul 17, 2017



Arti Hurria, MD, director, Cancer and Aging Research Program, co-leader, Cancer Control and Population Sciences Program, professor, Department of Medical Oncology and Therapeutics Research and Department of Population Sciences, discusses treatment for the geriatric patient population with breast cancer.

The aging process is heterogeneous, making it important to individualize medicine for the older population, explains Hurria.

By incorporating the principles of geriatrics into the oncologic care, the physician can receive a better understanding of the patient’s functional age in comparison to their chronological age, states Hurria.
 
SELECTED
LANGUAGE


Arti Hurria, MD, director, Cancer and Aging Research Program, co-leader, Cancer Control and Population Sciences Program, professor, Department of Medical Oncology and Therapeutics Research and Department of Population Sciences, discusses treatment for the geriatric patient population with breast cancer.

The aging process is heterogeneous, making it important to individualize medicine for the older population, explains Hurria.

By incorporating the principles of geriatrics into the oncologic care, the physician can receive a better understanding of the patient’s functional age in comparison to their chronological age, states Hurria.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: How Do We Leverage PARP Inhibition Strategies in the Contemporary Treatment of Breast Cancer?May 31, 20191.5
Community Practice Connections™: A Better Way to Stop Pain: Paths Toward Responsible Postsurgical Pain Management for Patients With Breast CancerMay 31, 20191.5
Publication Bottom Border
Border Publication
x